Sign in to view content

Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration

Justis P. Ehlers, MD, FASRS

Video
Published 2020

Related

Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates Continued Reduction in Geographic Atrophy Growth: 18-Month Results From GATHER1 Clinical Trial
Jason Hsu, MD
Annual Meeting Talks
2021
Feasibilty and Validation of a Deep-Learning Algorithm for the Detection of Macular Holes With Spectral Domain Optical Coherence Tomography
Jessica L. Cao, MD
Annual Meeting Talks
2021
Intraocular Implantation of the Argus II Retinal Prosthesis using Microscope Integrated OCT (MiOCT) Guidance
Avni P Finn, MD, MBA, FASRS
Lejla Vajzovic, MD, FASRS
Innovative Retina Surgical Video Series
2017

Category: AMD-Non-Neovascular

See more